Search for a command to run...
Ticker: HPL • | Sector: PHARMACEUTICALS
RevRevenue
~ AverageRs. 30.93 B
ProfitNet Profit
✓ GoodRs. 2.91 B
EPSEPS
✓ Good₨301.67
ROEROE
✓ Good35.5%
P/EP/E
~ Average13.0x
YieldDividend Yield
✓ Good6.1%
Hoechst Pakistan Limited has shown positive revenue growth of 15.6% over the past year. Net income has grown by 56.7% year-over-year. The company maintains a return on equity of 35.5%.
Company profile
HPL • PHARMACEUTICALS
Hoechst Pakistan Limited is a public limited Company incorporated in Pakistan under the repealed Companies Act, 1913 (Now the Companies Act, 2017). The Company is engaged in the manufacturing, selling and trading of pharmaceutical and related products. The Company has changed its name from Sanofi-Aventis Pakistan Limited to Hoechst Pakistan Limited.
HPL stock data provided by Ticker Analysts. Prices may be delayed. Data is for informational purposes only.